M6PR upregulation by berberine attenuates hepatic senescence via sorting STING into endosome for degradation

作者：Wenjuan Tang, Qianqian Zhang, Longyu Qin, Xinxin Yang, Dake Chu, Han Li, Jiaqi Zhang, Yanmin Zhang, Hongmei Zhang · 发表于：Phytomedicine · 年份：2025 · DOI：10.1016/j.phymed.2025.157089 · 被引用次数：5 · 研究领域：interferon and immune responses、RNA regulation and disease、Cytokine Signaling Pathways and Interactions

BACKGROUND: Cellular senescence is associated with various hepatic diseases. Stimulator of interferon genes (STING) signaling has been identified as a significant driver of cellular senescence and hepatic stellate cells (HSCs) activation. The blockade of STING signaling serves as a potential strategy to halt senescence. However, little is known about the anti-aging natural compound inhibiting STING signaling to date. PURPOSE: To screen natural compound targeting STING signaling, and to unearth its pharmacological actions and molecular mechanisms. METHODS: Natural compound inhibiting STING signaling was identified using RT-PCR, and anti-aging effects were systematically evaluated in doxorubicin (Dox)-induced senescent cells and natural aging mice, respectively. Exact pharmacological effects and molecular mechanisms were thoroughly investigated using inhibitors and agonists of the STING signaling, STING dimerization assay, bioinformatic analysis, Western blotting, immunoprecipitation, immunofluorescence and cell thermal shift assay. RESULTS: Here, marketed drug berberine (BBR), a natural compound, was identified as an inhibitor of STING signaling and a potential candidate for attenuating hepatic senescence. Mechanistically, STING was indeed overexpressed and over-activated to induce the production of interferon-beta (IFN-β) and other senescence-associated secretory phenotypes (SASPs), thereby initiating senescence process and HSCs activation in response to cell stress. We unexp...